(Q45413404)

14 December 2017

title

Rates and predictors of hepatitis C virus treatment in HCV-HIV-coinfected subjects (English)

1 reference

14 December 2017

1 reference

1 reference

Butt AA

1

1 reference

14 December 2017

Justice AC

2

1 reference

14 December 2017

Skanderson M

3

1 reference

14 December 2017

Good C

4

1 reference

14 December 2017

Kwoh CK

5

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

Alimentary Pharmacology & Therapeutics

14 December 2017

published in

1 reference

14 December 2017

volume

24

1 reference

14 December 2017

issue

4

1 reference

14 December 2017

page(s)

585-591

1 reference

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03020.X

Crossref

reference URL

Surprisingly small effect of antiviral treatment in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03020.X

Crossref

reference URL

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03020.X

Crossref

reference URL

10.1111/J.1365-2036.2006.03020.X

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference